Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report)‘s stock had its “neutral” rating reaffirmed by research analysts at ...

Designed to provide broad exposure to the Health Care ETFs category of the market, the First Trust Health Care AlphaDEX ETF (FXH) is a smart beta exchange traded fund launched on 05/08/2007. What Are ...

Stock analysts at StockNews.com initiated coverage on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) in a ...

Below is Validea's guru fundamental report for INTRA-CELLULAR THERAPIES INC (ITCI). Of the 22 guru strategies we follow, ITCI rates highest using our Quantitative Momentum Investor model based on ...

In a report released yesterday, Charles Duncan from Cantor Fitzgerald maintained a Hold rating on Intra-Cellular Therapies (ITCI – Research ...

Below is Validea's guru fundamental report for INTRA-CELLULAR THERAPIES INC (ITCI). Of the 22 guru strategies we follow, ITCI rates highest using our Quantitative Momentum Investor model based on ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $126.67, along ...

In this article, we are going to take a look at where Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) stands against other biotech stocks. Although biotech stocks had a “challenging” year in 2024, ...

In this article, we are going to take a look at where Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) stands against other best biotech stocks. Although biotech stocks had a “challenging” year in ...

Rigel Pharmaceuticals is now reporting net income and has three marketed drugs, all of which can continue to grow. Read more ...